Our Clinical Trials

This page highlights the active clinical trials at Memorial Sloan-Kettering for osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma. Other clinical trials are available for other sarcoma types; please call our doctors for more information.

Ewing's Sarcoma
Osteosarcoma
Rhabdomyosarcoma

Ewing's Sarcoma

top

A Phase II Study of Pemetrexed in Children with Recurrent Malignancies
Trippett, Tanya, MD

[Protocol 07-179]
A Phase II Study of Trabectedin in Children with Recurrent Rhabdomyosarcoma, Ewing's Sarcoma, or Nonrhabdomyosarcomatous Sarcomas
Wexler, Leonard, MD

[Protocol 08-145]
A Phase II Trial of R1507 for People with Recurrent Sarcoma
Maki, Robert, MD

[Protocol 07-166]
A Study of SCH 717454 in Patients with Osteosarcoma or Ewing's Sarcoma That Has Relapsed After Standard Systemic Therapy
Meyers, Paul, MD

[Protocol 08-134]

Osteosarcoma

top

A Phase II Study of Pemetrexed in Children with Recurrent Malignancies
Trippett, Tanya, MD

[Protocol 07-179]
A Phase II Trial of R1507 for People with Recurrent Sarcoma
Maki, Robert, MD

[Protocol 07-166]
A Study of SCH 717454 in Patients with Osteosarcoma or Ewing's Sarcoma That Has Relapsed After Standard Systemic Therapy
Meyers, Paul, MD

[Protocol 08-134]
Evaluating the Causes of Cancer in Young Patients
Stadler, Zsofia, MD

[Protocol 09-068]
Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine (L-MTP-PE): Compassionate Access for High-Risk Osteosarcoma
Meyers, Paul, MD

[Protocol 08-021]

Rhabdomyosarcoma

top

A Phase II Study of Pemetrexed in Children with Recurrent Malignancies
Trippett, Tanya, MD

[Protocol 07-179]
A Phase II Study of Trabectedin in Children with Recurrent Rhabdomyosarcoma, Ewing's Sarcoma, or Nonrhabdomyosarcomatous Sarcomas
Wexler, Leonard, MD

[Protocol 08-145]
A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma
Wexler, Leonard, MD

[Protocol 03-099]
A Phase II Trial of R1507 for People with Recurrent Sarcoma
Maki, Robert, MD

[Protocol 07-166]
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide in Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma
Wexler, Leonard, MD

[Protocol 05-032]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org